Share Email Print

Proceedings Paper

Bioconjugates of photosensitizers relevant for PDT
Author(s): N. A. Golubeva; Marina V. Demcheva; Elena B. Chernyaeva; Raisa I. Yakubovskaya; G. M. Suhin; Gelii V. Ponomarev; Maria G. Galpern; Eugeny A. Lukyanets; Alexander P. Savitsky
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The photodynamic therapy is highly promising for its dual specificity, namely, for the site of accumulation of the phototoxic substance and for the site of action of laser. A drawback of the PDT technique is a low selectivity of the photosensitizers accumulation in tumor tissue. Therapeutic doses of photosensitizers are fairly high, that leads to unfavorable effects (toxicoses, lesions of normal skin, prolonged rehabilitation). This drawback can be overcome is photoimmunotoxins are used, i.e. conjugates of photosensitizers with antibodies to specific tumor markers. We tried to introduce a simple model for estimation of singlet oxygen effect on cells for the case of free photosensitizers, presented in outside solution, and in case of conjugated dye, bound by cell surface receptors. To achieve the same effect the required concentration of conjugated photosensitizer can be significantly decreased (50 to 100 fold) as compared with free dye. Methods for porphyrins and different phthalocyanines and naphthalocyanines conjugation with protein were developed. The use of bacteriophage T4 as a model for studying the action of photoimmunotoxines on virus, unambiguously demonstrated the applicability of this approach for targeted destruction of viral particles.

Paper Details

Date Published: 8 January 1996
PDF: 16 pages
Proc. SPIE 2728, CIS Selected Papers: Laser Use in Oncology, (8 January 1996); doi: 10.1117/12.229485
Show Author Affiliations
N. A. Golubeva, Bach Institute of Biochemistry and Moscow State Univ. (Russia)
Marina V. Demcheva, Bach Institute of Biochemistry (Russia)
Elena B. Chernyaeva, Moscow State Univ. (Russia)
Raisa I. Yakubovskaya, P.A. Hertzen Moscow Research Oncology Institute (Russia)
G. M. Suhin, P.A. Hertzen Moscow Research Oncology Institute (Russia)
Gelii V. Ponomarev, Institute of Biomedical Chemistry (Russia)
Maria G. Galpern, Moscow Research and Production Association NIOPIC (Russia)
Eugeny A. Lukyanets, Moscow Research and Production Association NIOPIC (Russia)
Alexander P. Savitsky, Bach Institute of Biochemistry (Russia)

Published in SPIE Proceedings Vol. 2728:
CIS Selected Papers: Laser Use in Oncology
Andrei V. Ivanov; Mishik A. Kazaryan, Editor(s)

© SPIE. Terms of Use
Back to Top